The Pharmacokinetic and Safety Profiles of Blonanserin in Healthy Chinese Volunteers After Single Fasting Doses and Single and Multiple Postprandial Doses

[1] Falkai P(2005)World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part I: acute treatment of schizophrenia World J Biol Psychiatry 6 132-191

[2] Wobrock T(2009)Schizophrenia Lancet 374 635-645

[3] Lieberman I(2013)Profile of blonanserin for the treatment of schizophrenia Neuropsychiatr Dis Treat 9 587-594

[4] van Os J(2007)Pharmacological profile of blonanserin Jpn J Clin Psychopharmacol 10 1263-1272

[5] Kapur S(2013)Blonanserin for schizophrenia: systematic review and meta-analysis of double-blind, randomized, controlled trials J Psychiatr Res 47 149-154

[6] Tomomi T(2010)Blonanserin CNS Drugs 24 65-84

[7] Seiya M(2010)Effect of dose timing in relation to food intake on systemic exposure to blonanserin Eur J Clin Pharmacol 66 899-902

[8] Yuriko N(2012)Simultaneous determination of blonanserin and its metabolite in human plasma and urine by liquid chromatography–tandem mass spectrometry: application to a pharmacokinetic study J Chromatogr B 903 46-52

[9] Une T(2013)Simultaneous determination of blonanserin and its four metabolites in human plasma using ultra-performance liquid chromatography–tandem mass spectrometry J Chromatogr B Analyt Technol Biomed Life Sci 18 59-66

[10] Kurumiya S(2007)Gut instincts: CYP3A4 and intestinal drug metabolism J Clin Invest 117 3173-3176

[1] Falkai P(2005)World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part I: acute treatment of schizophrenia World J Biol Psychiatry 6 132-191

[2] Wobrock T(2009)Schizophrenia Lancet 374 635-645

[3] Lieberman I(2013)Profile of blonanserin for the treatment of schizophrenia Neuropsychiatr Dis Treat 9 587-594

[4] van Os J(2007)Pharmacological profile of blonanserin Jpn J Clin Psychopharmacol 10 1263-1272

[5] Kapur S(2013)Blonanserin for schizophrenia: systematic review and meta-analysis of double-blind, randomized, controlled trials J Psychiatr Res 47 149-154

[6] Tomomi T(2010)Blonanserin CNS Drugs 24 65-84

[7] Seiya M(2010)Effect of dose timing in relation to food intake on systemic exposure to blonanserin Eur J Clin Pharmacol 66 899-902

[8] Yuriko N(2012)Simultaneous determination of blonanserin and its metabolite in human plasma and urine by liquid chromatography–tandem mass spectrometry: application to a pharmacokinetic study J Chromatogr B 903 46-52

[9] Une T(2013)Simultaneous determination of blonanserin and its four metabolites in human plasma using ultra-performance liquid chromatography–tandem mass spectrometry J Chromatogr B Analyt Technol Biomed Life Sci 18 59-66

[10] Kurumiya S(2007)Gut instincts: CYP3A4 and intestinal drug metabolism J Clin Invest 117 3173-3176